Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease - Dabora, S L; Franz, D N; Ashwal, S (PLoS ONE, 2011)
, et al.